Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael C Sheppard

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Clinical Medicine (London, England)|November 13, 2004
Growth hormone--from molecule to mortalityMichael C Sheppard
Clinical Endocrinology|January 17, 2007
Growth hormone assay standardization: an important clinical advanceMichael C Sheppard
Nature Clinical Practice. Endocrinology & Metabolism|October 7, 2006
Growth hormone therapy does not induce cancerMichael C Sheppard
Clinical Endocrinology|March 19, 2003
Primary medical therapy for acromegalyMichael C Sheppard
Expert Opinion on Pharmacotherapy|October 27, 2004
The role of growth hormone-receptor antagonism in relation to acromegalyJohn Ayuk, Michael C Sheppard
Reviews in Endocrine & Metabolic Disorders|December 14, 2007
Does acromegaly enhance mortality?John Ayuk, Michael C Sheppard
Nature Reviews. Endocrinology|March 31, 2011
Medical therapy in acromegalyMark Sherlock, Conor Woods, Michael C Sheppard
Archives of Internal Medicine|February 28, 2002
Levothyroxine treatment and occurrence of fracture of the hipMichael C Sheppard, Roger Holder, Jayne A Franklyn
JAMA|July 7, 2005
Thyroid function and mortality in patients treated for hyperthyroidismJayne A Franklyn, Michael C Sheppard, Patrick Maisonneuve
Clinical Endocrinology|March 11, 2004
Efficacy of Sandostatin LAR (long-acting somatostatin analogue) is similar in patients with untreated acromegaly and in those previously treated with surgery and/or radiotherapyJohn Ayuk, Susan E Stewart, Paul M Stewart, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Clinical Medicine (London, England)|November 13, 2004
Growth hormone--from molecule to mortalityMichael C Sheppard
Clinical Endocrinology|January 17, 2007
Growth hormone assay standardization: an important clinical advanceMichael C Sheppard
Nature Clinical Practice. Endocrinology & Metabolism|October 7, 2006
Growth hormone therapy does not induce cancerMichael C Sheppard
Clinical Endocrinology|March 19, 2003
Primary medical therapy for acromegalyMichael C Sheppard
Expert Opinion on Pharmacotherapy|October 27, 2004
The role of growth hormone-receptor antagonism in relation to acromegalyJohn Ayuk, Michael C Sheppard
Reviews in Endocrine & Metabolic Disorders|December 14, 2007
Does acromegaly enhance mortality?John Ayuk, Michael C Sheppard
Nature Reviews. Endocrinology|March 31, 2011
Medical therapy in acromegalyMark Sherlock, Conor Woods, Michael C Sheppard
Archives of Internal Medicine|February 28, 2002
Levothyroxine treatment and occurrence of fracture of the hipMichael C Sheppard, Roger Holder, Jayne A Franklyn
JAMA|July 7, 2005
Thyroid function and mortality in patients treated for hyperthyroidismJayne A Franklyn, Michael C Sheppard, Patrick Maisonneuve
Clinical Endocrinology|March 11, 2004
Efficacy of Sandostatin LAR (long-acting somatostatin analogue) is similar in patients with untreated acromegaly and in those previously treated with surgery and/or radiotherapyJohn Ayuk, Susan E Stewart, Paul M Stewart, et al.
Pageof 2